Akses terbuka
Jurnal
SINTA 1
Increased Level of The Plasminogen Activator Inhibitor Type-1 is Associated with Severity of NAFLD
Journal of Biomedicine and Translational Research · Vol. 9 No. 2 (2023) · hlm. 47–54
ISSN 2503-2178
Terbit 2023-08-31
Penerbit Faculty of Medicine, Universitas Diponegoro
Bahasa eng
Abstrak
Background: Non-Alcoholic Fatty Liver Disease (NAFLD) has been the most common cause of chronic liver disease worldwide. In NAFLD, elevated Plasminogen Activator Inhibitor-1 (PAI-1) is associated with risk factors for thrombosis and hypercoagulable state.Objective: This study explored the relationship between NAFLD as an independent factor for increasing PAI-1 in the presence of metabolic syndrome and insulin resistance.Methods: This observational study used a cross-sectional design with 80 subjects including 40 patients with NAFLD and 40 without NAFLD at dr. Kariadi Semarang who met the inclusion and exclusion criteria. Measurement of plasma PAI-1 levels was done using ELISA method.Results: A total of 80 patients were included. In the case group, based on abdominal ultrasound, NAFLD was mostly found in the mild category (86%), while the rest were moderate (10%), and severe (4%). Only 25% were found in the Simple Steatosis category, and 75% were suspected of having NASH (NAS = 3-4) and NASH (NAS > 5). There was a significant difference between plasma PAI-1 level and the incidence of NAFLD (p = 0.011). The mean PAI-1 level between the three NAFLD severity categories also shown a significant difference (p = 0.032).Conclusion: There is an increase in PAI-1 levels in patients with NAFLD. PAI-1 levels have an independent effect on the degree of liver fibrosis in patients with NAFLD.
Jaringan kolaborasi para penulis
25 penulis ·
76 tautan kepenulisan bersama
Arahkan kursor atau ketuk sebuah nama untuk menyorot rekan penulisnya. Klik dua kali untuk membuka halaman penulis.
Organisasi berbeda
Organisasi sama
Afiliasi tidak diketahui
Garis lebih tebal = lebih banyak artikel bersama · lingkaran lebih besar = lebih banyak artikel
Tampilkan sebagai tabel
Afiliasi berasal dari OpenAlex; metadata OAI-PMH jurnal tidak memuatnya. Penulis tanpa ID OpenAlex dicocokkan berdasarkan nama, sehingga dua orang bisa tergabung atau satu orang bisa terpisah.
Sumber metadata: OAI-PMH (metadata jurnal) https://ejournal2.undip.ac.id/index.php/jbtr/oai, pertama di-harvest 9 Nov 2026, terakhir terlihat 16 Nov 2026.
Metadata asli (oai_dc)
<oai_dc:dc xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
<dc:title xml:lang="en-US">Increased Level of The Plasminogen Activator Inhibitor Type-1 is Associated with Severity of NAFLD</dc:title>
<dc:creator>Indiarso, Didik</dc:creator>
<dc:creator>Prasetyo, Agung</dc:creator>
<dc:creator>Hirlan, Hirlan</dc:creator>
<dc:creator>Purnomo, Hery Djagat</dc:creator>
<dc:subject xml:lang="en-US">NAFLD; NASH; PAI-1; liver fibrosis</dc:subject>
<dc:description xml:lang="en-US">Background: Non-Alcoholic Fatty Liver Disease (NAFLD) has been the most common cause of chronic liver disease worldwide. In NAFLD, elevated Plasminogen Activator Inhibitor-1 (PAI-1) is associated with risk factors for thrombosis and hypercoagulable state.Objective: This study explored the relationship between NAFLD as an independent factor for increasing PAI-1 in the presence of metabolic syndrome and insulin resistance.Methods: This observational study used a cross-sectional design with 80 subjects including 40 patients with NAFLD and 40 without NAFLD at dr. Kariadi Semarang who met the inclusion and exclusion criteria. Measurement of plasma PAI-1 levels was done using ELISA method.Results: A total of 80 patients were included. In the case group, based on abdominal ultrasound, NAFLD was mostly found in the mild category (86%), while the rest were moderate (10%), and severe (4%). Only 25% were found in the Simple Steatosis category, and 75% were suspected of having NASH (NAS = 3-4) and NASH (NAS > 5). There was a significant difference between plasma PAI-1 level and the incidence of NAFLD (p = 0.011). The mean PAI-1 level between the three NAFLD severity categories also shown a significant difference (p = 0.032).Conclusion: There is an increase in PAI-1 levels in patients with NAFLD. PAI-1 levels have an independent effect on the degree of liver fibrosis in patients with NAFLD.</dc:description>
<dc:publisher xml:lang="en-US">Faculty of Medicine, Universitas Diponegoro</dc:publisher>
<dc:date>2023-08-31</dc:date>
<dc:type>info:eu-repo/semantics/article</dc:type>
<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
<dc:type xml:lang="en-US"></dc:type>
<dc:format>application/pdf</dc:format>
<dc:identifier>https://ejournal2.undip.ac.id/index.php/jbtr/article/view/16293</dc:identifier>
<dc:identifier>10.14710/jbtr.v9i2.16293</dc:identifier>
<dc:source xml:lang="en-US">Journal of Biomedicine and Translational Research; Vol 9, No 2 (2023): August 2023; 47-54</dc:source>
<dc:source>2503-2178</dc:source>
<dc:source>10.14710/jbtr.v9i2</dc:source>
<dc:language>eng</dc:language>
<dc:relation>https://ejournal2.undip.ac.id/index.php/jbtr/article/view/16293/9644</dc:relation>
<dc:relation>https://ejournal2.undip.ac.id/index.php/jbtr/article/downloadSuppFile/16293/4016</dc:relation>
<dc:relation>https://ejournal2.undip.ac.id/index.php/jbtr/article/downloadSuppFile/16293/4017</dc:relation>
<dc:relation>https://ejournal2.undip.ac.id/index.php/jbtr/article/downloadSuppFile/16293/4018</dc:relation>
<dc:rights xml:lang="en-US">Copyright (c) 2023 Journal of Biomedicine and Translational Research</dc:rights>
<dc:rights xml:lang="en-US">https://creativecommons.org/licenses/by-sa/4.0</dc:rights>
</oai_dc:dc>
Sitasi dan pengindeksan
OpenAlex
Terindeks
lewat DOI
2 sitasi
Crossref
Belum diperiksa
Jumlah menurut tiap indeks pada 13 Nov 2026; setiap indeks menghitung sitasi dengan cara berbeda.
OpenAlex juga mencatat karya ini di: crossref.
Sitasi artikel ini
APA 7
Indiarso, D., Prasetyo, A., Hirlan, H., & Purnomo, H. D. (2023). Increased Level of The Plasminogen Activator Inhibitor Type-1 is Associated with Severity of NAFLD. Journal of Biomedicine and Translational Research, 9(2), 47–54. https://doi.org/10.14710/jbtr.v9i2.16293
Salin
IEEE
D. Indiarso, A. Prasetyo, H. Hirlan, and H. D. Purnomo, “Increased Level of The Plasminogen Activator Inhibitor Type-1 is Associated with Severity of NAFLD,” Journal of Biomedicine and Translational Research, vol. 9, no. 2, pp. 47–54, 2023, doi: 10.14710/jbtr.v9i2.16293.
Salin
Dibuat dari metadata jurnal; periksa nama penulis sebelum dipakai.